Clinical Trial Update: A Healthy Volunteer Study With Inhaled GSK573719 and Placebo [Phase 1]

View source ↗

Summary

Phase 1 healthy volunteer study of inhaled GSK573719 versus placebo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED